I'm guessing some LT holders in for a second bite at the cherry...

I'm guessing some LT holders in for a second bite at the cherry like myself have understood the significance of having to pay someone to take microstreak, honestly I'm still in shock and reducing my holding.
The only shareholder value ever created in this stock was through investor stupidity when the FDA approval was announced, .17c-$1.09 in 3 days pushed by investors that didn't have a clue and it then took 10 weeks to settle back to where it belonged.
Over the years management haven't learnt or changed and investors are realising they probably won't so even if APAS like microstreak is a success at this rate by the time they start to realise its commercial potential it also will be obsolete.
This is just becoming to frustrating to watch let alone be seriously invested in.